Funder
Research Grants Council, Hong Kong
HKU-USydney Strategic Partnership Fund
Reference47 articles.
1. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection;Arora;Mol. Pharm.,2015
2. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability;Arora;Expert Opin. Drug Deliv.,2016
3. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice;Beinborn;Eur. J. Pharm. Biopharm.,2012
4. Benito, M., Molins, E., Contreras, J., 2012. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof. Patent WO2007132354A2.
5. A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis;Chan;Emerg. Microbes Infect.,2016
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献